Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/09/2003WO2002080939A3 Ionene polymers and their use as antimicrobial agents
10/09/2003WO2002078747A3 Pregabalin lactose conjugates
10/09/2003WO2002078682A3 Estrogen replacement therapy
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002074056A3 Allosteric adenosine receptor modulators
10/09/2003WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
10/09/2003WO2002067928A3 Metronomic dosing of taxanes for inhibiting tumor growth
10/09/2003WO2002060375A3 Diphenyl ether derivatives and their uses as heparanase inhibitors
10/09/2003WO2002058687A3 Inhibition of erk to reduce or prevent tolerance to and dependence on opioid analgesics
10/09/2003WO2002055063A3 Fumaric acid amides
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
10/09/2003WO2002049599A3 Filtering composition containing a 1,3,5-triazine derivative, a dibenzoylmethane derivative, and a 4,4-diarylbutadiene compound
10/09/2003WO2002047680A9 Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia
10/09/2003WO2002043769A3 Neutral and anionic colloidal particles for gene delivery
10/09/2003WO2002034284A3 Methods of therapy for hiv infection
10/09/2003WO2002034246A3 Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
10/09/2003WO2002030357A9 Compounds and methods for modulating ccr4 function
10/09/2003WO2002026245A3 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
10/09/2003WO2002016636A3 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders
10/09/2003WO2002015841A3 Medicine for treating female sexual dysfunction by acting on the central nervous system
10/09/2003WO2002010382A3 Trp8, trp9 and trp10, markers for cancer
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003US20030191347 Venlafaxine base
10/09/2003US20030191332 Prevention of neutrophil recruitment
10/09/2003US20030191323 An acylsulfonamide derivatives having insulin resistance, used as enzyme inhibitor of acetyl CoA carboxylase, preventing and curing diabetes
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191315 A chemical intermediate reaction by starting 2,6-diaminopyridine with malic acid and sulfuric acid, salt formation, hydroxylation, chlorination, dehydroxylation, reduction, esterification
10/09/2003US20030191312 Preparing a C2-substituted purine compound, by reacting a C2-halogenated purine with a boronic acid, a hydroxy or amine compounds; dehydrohalogenation, amination, carboxylation; chemical intermediates
10/09/2003US20030191311 Imidazole derivatives
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191300 Antisense modulation of bcl-x expression
10/09/2003US20030191296 Erythromycin derivative having novel crystal structures and processes for their production
10/09/2003US20030191271 New polyester polyurethanes, process for preparaing them, pseudolatices produced from the said polyester polyurethanes and their use in cosmetic compositions
10/09/2003US20030191192 Aqueous suspension of drug; storage stability
10/09/2003US20030191191 Central nervous system disorders; side effect reduction of cancer therapy
10/09/2003US20030191188 Method for treating migraine symptoms with ibuprofen and salts thereof
10/09/2003US20030191187 Aqueous solution containing phosphate; adjustment pH
10/09/2003US20030191186 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
10/09/2003US20030191185 Hormone replacement therapy
10/09/2003US20030191184 Antiinflammatory agents; prevent boactericide diffusion; using fatty acids
10/09/2003US20030191183 Nasal administering; side effect reduction; bioavailability
10/09/2003US20030191181 4-[(8-Ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome P450RAI inhibitory activity
10/09/2003US20030191180 Pharmaceutical compositions
10/09/2003US20030191179 Methods for administration of paclitaxel
10/09/2003US20030191178 Therapy for vision defects; hypotensive agents; respiratory system disorders
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191176 Stable hydrate of a muscarinic receptor antagonist
10/09/2003US20030191175 Indole sPLA2 inhibitors
10/09/2003US20030191173 Method for treating ocular hypertension
10/09/2003US20030191172 Method of using cyclooxygenase inhibitors and antimuscarinic agents
10/09/2003US20030191170 Central nervous system disorders; antiallergens; respiratory system disorders
10/09/2003US20030191169 Methods for increasing the survival of aquatic and other animals exposed to an aquatic virus, birnavirus or other RNA virus and compositions for such methods
10/09/2003US20030191167 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents
10/09/2003US20030191164 Propane-1,3-dione derivatives
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191162 Skin disorders; brain cancer; angiogenesis inhibitor
10/09/2003US20030191161 Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom
10/09/2003US20030191160 Aids therapy; calibration efficiency of benzimidazole compound
10/09/2003US20030191159 Antisecretory agents; antiulcer agents; adjust absorption
10/09/2003US20030191158 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
10/09/2003US20030191157 Injections
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191155 Triazole derivatives
10/09/2003US20030191153 Antithrombotic amides
10/09/2003US20030191152 Use of halogenated heterocyclic compounds in the treatment of sexual dysfunction and cardiovascular disease
10/09/2003US20030191151 Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/09/2003US20030191149 Compounds for treating fibromyalgia and chronic fatigue syndrome
10/09/2003US20030191148 Macrolides
10/09/2003US20030191147 Alcoholism, drug abuse, antidepressants
10/09/2003US20030191146 Oxidoreductase inhibitors; bacteriostats, bactericides
10/09/2003US20030191145 Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and in cosmetics
10/09/2003US20030191143 Attenuation immunology response; antiproliferative agents; rheumatic diseases; hypotensive agents; antilipemic agents; anticholesterol agents
10/09/2003US20030191141 Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof
10/09/2003US20030191140 Psychological disorders; dissolving in solvent, crystallization
10/09/2003US20030191137 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
10/09/2003US20030191136 Melanin concentrating hormone receptor ligands
10/09/2003US20030191133 Indole derivatives useful for the treatment of CNS disorders
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191131 Veterinary medicine; anticancer agents
10/09/2003US20030191130 [1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists
10/09/2003US20030191129 Antitumor agents
10/09/2003US20030191128 Anticancer agents; antiproliferative agent
10/09/2003US20030191125 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof
10/09/2003US20030191124 Derivatives of sulphonamides, their preparation and use as medicaments
10/09/2003US20030191123 2-amino-benzoxazinone derivatives for the treatment of obesity
10/09/2003US20030191122 Antidepressants; Alzheimer's disease; Parkinson's disease; central nervous system disorders
10/09/2003US20030191120 Antiparkinsonism drugs
10/09/2003US20030191119 Alzheimer's disease
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191117 Acyclic piperazine and piperidine derivatives
10/09/2003US20030191116 Gastrin and cholecystokinin receptor ligands (III)
10/09/2003US20030191115 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
10/09/2003US20030191114 Binding to ligand; induce signals
10/09/2003US20030191113 For agriculture
10/09/2003US20030191111 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191109 Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
10/09/2003US20030191108 N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant staphylococcus aureus
10/09/2003US20030191105 7-acylamino-3-(imino)methyl cephalosporins; 7-[[(5-Amino-1,2,4-thiadiazol-3-yl)-(Z)-(fluormethoxyimino)acetyl]amino]-3-[[(piperazinoiminomethyl)hydrazono]methyl]-3-cephem-4-carboxylic acid; imination of 3-methyl derivative; acylation at the 7-amino; 1-[hydrazino(methylimino)methyl]piperazine intermediate
1 ... 5315 5316 5317 5318 5319 5320 5321 5322 5323 5324 5325 5326 5327 5328 5329 5330 5331 5332 5333 5334 5335 ... 7860